IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

YS Biopharma Co LTD

CUSIP: G9845F109 | 27 institutional holders

Quarters

Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2024

FMR LLC1,165,071
0.0% of portfolio›$802.7K
Hhlr Advisors, Ltd.751,790
0.0% of portfolio›$512.7K
FIL Ltd615,475
0.0% of portfolio›$424.1K
Superstring Capital Management LP307,920
0.2% of portfolio›$212.2K
Barclays PLC247,575
0.0% of portfolio›$168.8K
Bank of Montreal93,808
0.0% of portfolio›$75.5K
UBS Group AG49,418
0.0% of portfolio›$33.7K
Proequities, Inc.0
0.0% of portfolio›$0
StyleTurnoverLocationFiled
FMR LLC
1,165,071$802.7K0.0%GrowthMediumBoston, MA2026-11-05
Hhlr Advisors, Ltd.
751,790$512.7K0.0%GARPMediumGrand Cayman, Germany2024-11-14
FIL Ltd
615,475$424.1K0.0%ValueMediumHamilton, Denmark2024-11-13
Superstring Capital Management LP
307,920$212.2K0.2%CoreVery HighNew York, NY2024-11-14
Barclays PLC
247,575$168.8K0.0%CoreMediumLondon, United Kingdom2026-03-31
Bank of Montreal
93,808$75.5K0.0%CoreLowToronto, Australia2024-11-13
UBS Group AG
49,418$33.7K0.0%CoreMediumZurich, Switzerland2024-11-14
Proequities, Inc.
0$00.0%GrowthVery LowBirmingham, AL2024-10-10